Status:

COMPLETED

ADVANCE- Automated Detection and Volumetric Assessment of ICH

Lead Sponsor:

Viz.ai, Inc.

Conditions:

Intracerebral Hemorrhage

Eligibility:

All Genders

18+ years

Brief Summary

To evaluate the performance of the Viz ICH VOLUME algorithm.

Detailed Description

To evaluate the performance of the Viz ICH VOLUME algorithm to: 1. detect the presence of ICH on brain imaging, 2. measure the volume of ICH on brain imaging, 3. and to assess the algorithm processin...

Eligibility Criteria

Inclusion

  • Adult patients (18 and older)
  • Presenting with symptoms suspicious for an acute stroke / intracranial hemorrhage
  • Having a complete imaging data set including NCCT +/- MRI, CTA and/or MRA

Exclusion

  • Subjects with poor or incomplete brain imaging.

Key Trial Info

Start Date :

January 26 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 28 2023

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT04733638

Start Date

January 26 2021

End Date

April 28 2023

Last Update

September 19 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Swedish Medical Center Healthone

Englewood, Colorado, United States, 80113

2

Mount Sinai Hospital (Neurosurgery)

New York, New York, United States, 10029

3

Presbyterian Medical Center

Charlotte, North Carolina, United States, 28204

4

Forsyth Medical Center

Winston-Salem, North Carolina, United States, 27103

ADVANCE- Automated Detection and Volumetric Assessment of ICH | DecenTrialz